Metabolix (YTEN)
(Delayed Data from NSDQ)
$0.22 USD
-0.02 (-7.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.22 0.00 (-0.81%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
YTEN 0.22 -0.02(-7.20%)
Will YTEN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for YTEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for YTEN
Corteva, Inc. (CTVA) Beats Q1 Earnings and Revenue Estimates
ADT and CarMax have been highlighted as Zacks Bull and Bear of the Day
YTEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Under-$3 Consumer Staple Stocks Wall Street Analysts Recommend Buying
Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates
Corteva, Inc. (CTVA) Reports Q3 Loss, Tops Revenue Estimates
Other News for YTEN
Yield10 Bioscience files to sell 6.38M shares of common stock for holders
Yield10 Bioscience files to sell 6.38M shares of common stock for holders
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
Hold Recommendation on Yield10 Bioscience Amid Commercialization and Capital Uncertainties